BYSI (BeyondSpring) E10: $-2.03 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BYSI BeyondSpring Inc BYSI
25 GF Score
Price $0.62
! 2 Warning Signs
View Full Analysis

What is BeyondSpring E10?

BeyondSpring BYSI -2.28% 25 E10 is $-2.03 as of Jun. 2026. GuruFocus rates BYSI with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BeyondSpring's adjusted earnings per share data for the three months ended in Jun. 2026 was $-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.03 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-04), BeyondSpring's current stock price is $0.61935. BeyondSpring's E10 for the quarter that ended in Jun. 2026 was $-2.03. BeyondSpring's Shiller PE Ratio of today is .


BeyondSpring  (NAS:BYSI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BeyondSpring E10 Related Terms


BeyondSpring E10 Historical Data

* Premium members only.

The historical data trend for BeyondSpring's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BeyondSpring E10 Chart

BeyondSpring Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BeyondSpring Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -2.03

BYSI vs PLRZ, CVM, NXTC: E10 Comparison

For the Biotechnology subindustry, BeyondSpring's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeyondSpring Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeyondSpring's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BeyondSpring's Shiller PE Ratio falls into.


BYSI
25GF Score
BeyondSpring Inc BYSI
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BeyondSpring E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BeyondSpring's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.02/333.9520*333.9520
=-0.020

Current CPI (Jun. 2026) = 333.9520.

BeyondSpring Quarterly Data

per share eps CPI Adj_EPS
201412 0.000 234.812 0.000
201512 -0.127 236.525 -0.179
201603 -0.117 238.132 -0.164
201606 -0.224 241.018 -0.310
201609 -0.183 241.428 -0.253
201612 -0.209 241.432 -0.289
201703 -2.660 243.801 -3.644
201706 -0.610 244.955 -0.832
201709 -0.680 246.819 -0.920
201712 -0.670 246.524 -0.908
201803 -0.610 249.554 -0.816
201806 -0.540 251.989 -0.716
201809 -0.650 252.439 -0.860
201812 -0.610 251.233 -0.811
201903 -0.320 254.202 -0.420
201906 -0.320 256.143 -0.417
201909 -0.370 256.759 -0.481
201912 -0.540 256.974 -0.702
202003 -0.580 258.115 -0.750
202006 -0.460 257.797 -0.596
202009 -0.480 260.280 -0.616
202012 -0.520 260.474 -0.667
202103 -0.440 264.877 -0.555
202106 -0.490 271.696 -0.602
202109 -0.470 274.310 -0.572
202112 -0.240 278.802 -0.287
202206 0.000 296.311 0.000
202212 0.000 296.797 0.000
202306 0.000 305.109 0.000
202312 0.000 306.746 0.000
202403 -0.080 312.332 -0.086
202406 -0.100 314.175 -0.106
202409 -0.050 315.301 -0.053
202412 -0.040 315.605 -0.042
202503 0.110 319.799 0.115
202506 -0.040 322.561 -0.041
202509 -0.040 324.800 -0.041
202512 -0.050 324.054 -0.052
202603 -0.050 330.213 -0.051
202606 -0.020 333.952 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-2.03 mean?
BeyondSpring (BYSI) has a E10 of $-2.03 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BeyondSpring and its competitors.
Is BeyondSpring's E10 too high?
BeyondSpring's current E10 is $-2.03. Overall, BeyondSpring has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does BeyondSpring's E10 compare to PLRZ and CVM?
BeyondSpring's E10 of $-2.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BeyondSpring and its competitors. BeyondSpring's current E10 is $-2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BeyondSpring stock overvalued right now?
BeyondSpring (BYSI) has a current E10 of $-2.03. The current E10 is $-2.03. BeyondSpring's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BeyondSpring (BYSI), the current E10 is $-2.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BeyondSpring Business Description

Address 100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
25GF Score

Get the complete analysis for BYSI

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.62
Price